RNAIMMUNE
Live / Applied — Third extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 28 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97911833
- Mark type
- Stylized text
- Filed
- 28 Apr 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Leesa N. Weiss
Goods and services
- Class 005 — Pharmaceuticals: vaccines for infectious disease, cancer, heart disease, and rare diseases; therapeutic preparations for the treatment of cancer, heart disease and rare hereditary and infectious diseases
- Class 044 — Medical, beauty and agricultural services: immunotherapy, stem cell therapy, and chemotherapy for the treatment cancer, heart disease and rare hereditary and infectious diseases
Owner
- RNAIMMUNE, INC., Germantown, MD, US
- RNAIMMUNE, INC., Germantown, MD, US
Prosecution history
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 3 GRANTED
- 14 Jan 2026 — SOU EXTENSION 3 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2026 — SOU EXTENSION 2 GRANTED
- 06 Aug 2025 — SOU EXTENSION 2 FILED
- 12 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Nov 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 03 Nov 2025 — NOTICE OF REVIVAL - E-MAILED
- 03 Nov 2025 — PETITION TO REVIVE-GRANTED
- 03 Nov 2025 — TEAS PETITION TO REVIVE RECEIVED
- 08 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED